Latest Bioethics Stories
A Review of Conditions that Can Be Caused by Bioterrorism BALTIMORE, March 4, 2015 /PRNewswire-USNewswire/ -- In an article published and posted online today, senior scholars at the
Cell and gene therapy non-profit names new advisory council chairman and chairman emeritus Stamford, CT (PRWEB) February 20, 2015 World-renowned scientist
Heat Stable Ricin Toxin Vaccine Elicits Strong Immune Responses and Protects Animals from Ricin Intoxication PRINCETON, N.J., Feb. 13, 2015 /PRNewswire/ -- Soligenix, Inc.
Company presents data from research studies at ASM Biodefense conference this week PINE BROOK, N.J., Feb. 12, 2015 /PRNewswire/ -- Elusys Therapeutics, Inc.
Market Publishers Ltd announces that in-demand pipelines assessments prepared by DelveInsight have been recently added to its catalogue. London, UK (PRWEB) February
- Nuvo to Host Conference Call/Webcast at 8:30 a.m. ET - MISSISSAUGA, ON, Jan. 30, 2015 /PRNewswire/ - Nuvo Research Inc.
Latest report, "Global Biodefense Market Analysis, Size And Segment Forecasts To 2020," is available at Grand View Research database.
DUBLIN, January 27, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/p54ckt/the_market_for) has announced the addition of the "The
MELBOURNE, Australia, Jan.
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A serpent whose bite was fabled to produce intense thirst.
More Images (1 images) »